Skip to main content
Cameron Brennan, MD, Neurosurgery, New York, NY, Memorial Sloan Kettering Cancer Center

CameronWBrennanMDFAANS

Neurosurgery New York, NY

Brain & Spinal Tumor, Skull Base

Attending Surgeon, Memorial Sloan-Kettering Cancer Center

Overview of Dr. Brennan

Dr. Cameron Brennan is a neurosurgeon in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Weill Cornell Medicine and has been in practice 23 years. Dr. Brennan accepts several types of health insurance, listed below. He is one of 28 doctors at Memorial Sloan Kettering Cancer Center who specialize in Neurosurgery. He has more than 100 publications and over 500 citings.

Education & Training

  • Dana-Farber Cancer Institute
    Dana-Farber Cancer InstitutePost-Doctoral Fellowship, Molecular Oncology, 2001 - 2004
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Neurosurgical Oncology, 2000 - 2001
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurological Surgery, 1995 - 2000
  • New York Presbyterian Hospital
    New York Presbyterian HospitalInternship, Transitional Year, 1994 - 1995
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1994

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 1998 - 2025
  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Top Doctor, Neurosurgery New York Magazine, 2018
  • Top Doctors, NY Metro Area Castle Connolly, 2017-2018

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • When Does a Pounding Headache Actually Signal a Brain Tumor?
    When Does a Pounding Headache Actually Signal a Brain Tumor?June 16th, 2021
  • G-quadruplex DNA Drives Genomic Instability and Represents a Targetable Molecular Abnormality in ATRX-Deficient Malignant Glioma
    G-quadruplex DNA Drives Genomic Instability and Represents a Targetable Molecular Abnormality in ATRX-Deficient Malignant GliomaFebruary 26th, 2020

Grant Support

  • Genomics &BioinformaticsNational Cancer Institute2008–2011

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment